Trial Profile
The clinical study for evaluating the early efficacy and safety of alpha-1-adrenoreceptor antagonists in patient with benign prostatic hyperplasia.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Silodosin (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 08 Mar 2011 New trial record